Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
Xiaolin Wu, Jiahui Li, Asmae Gassa, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 9, pp. 1551-1562
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
Chen Shen, Xin Jiang, Mei Li, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 81
Circulating Tumor Cells and DNA in Early Diagnosis and Prognosis of Metastatic Cancer
Marium Jahan, A. Rubab, Mohsin Ali, et al.
IntechOpen eBooks (2025)
Closed Access | Times Cited: 2
Global mapping of cancers: The Cancer Genome Atlas and beyond
Carlo Ganini, Ivano Amelio, Riccardo Bertolo, et al.
Molecular Oncology (2021) Vol. 15, Iss. 11, pp. 2823-2840
Open Access | Times Cited: 79
Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
Adriana Torres Crigna, Marek Samec, Lenka Koklesová, et al.
The EPMA Journal (2020) Vol. 11, Iss. 4, pp. 603-627
Open Access | Times Cited: 73
When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review
July Rodríguez, Jenny Ávila, Christian Rolfo, et al.
Oncology and Therapy (2021) Vol. 9, Iss. 1, pp. 89-110
Open Access | Times Cited: 58
Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma
Daniela Gabbia, Sara De Martin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3441-3441
Open Access | Times Cited: 24
Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma
Ming-Da Wang, Yong‐Kang Diao, Lan‐Qing Yao, et al.
iLiver (2024) Vol. 3, Iss. 1, pp. 100083-100083
Open Access | Times Cited: 16
Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
Yurong Qin, Miaozhe Huo, Xingwu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Hepatocellular Carcinoma
Monika Vyas, Xuchen Zhang
Clinics in Liver Disease (2020) Vol. 24, Iss. 4, pp. 591-610
Closed Access | Times Cited: 54
Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective
Arun Kadamkulam Syriac, Nitish Singh Nandu, José Pablo Leone
Breast Cancer Targets and Therapy (2022) Vol. Volume 14, pp. 1-13
Open Access | Times Cited: 34
The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review
Agnieszka Kopystecka, Rafał Patryn, Magdalena Leśniewska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9342-9342
Open Access | Times Cited: 21
Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer
Syeda Maheen Batool, Tiffaney Hsia, Alexandra Beecroft, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 10, pp. 101196-101196
Open Access | Times Cited: 21
Methylomics and cancer: the current state of methylation profiling and marker development for clinical care
Chengyin Liu, Han Tang, Nana Hu, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 20
The Role of Cancer Stem Cell-Derived Exosomes in Cancer Progression
Xueting Li, Xinjian Li, Bin Zhang, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 28
Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors
Tina Draškovič, Nina Zidar, Nina Hauptman
Cancers (2023) Vol. 15, Iss. 3, pp. 859-859
Open Access | Times Cited: 16
Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma
Jun Ho Ji, Sang Yun Ha, Danbi Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7640-7640
Open Access | Times Cited: 15
Advances in Histological and Molecular Classification of Hepatocellular Carcinoma
Joon Hyuk Choi, Swan N. Thung
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2582-2582
Open Access | Times Cited: 15
Research on liquid biopsy for cancer: A bibliometric analysis
Shitao Jiang, Y. Liu, Yiyao Xu, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e14145-e14145
Open Access | Times Cited: 14
Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges
Lingyu Li, Yingli Sun
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 6
Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2749-2749
Open Access | Times Cited: 35
Exploring genetic alterations in circulating tumor DNA from cerebrospinal fluid of pediatric medulloblastoma
Yanling Sun, Miao Li, Siqi Ren, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021
Pasquale Pisapia, José Luís Costa, Francesco Pepe, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 161, pp. 103311-103311
Closed Access | Times Cited: 32
The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients
Bo Zheng, Xiao-Long Liu, Rong Fan, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 13, pp. 3772-3783
Open Access | Times Cited: 31
Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease
María Arechederra, Miriam Recalde, María Gárate‐Rascón, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1265-1265
Open Access | Times Cited: 30
Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
Maria Pallozzi, Natalia Di Tommaso, Valeria Maccauro, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4631-4631
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top